Insider · CIK 0001913228
Sergei Gryaznov
Files at MAIA (MAIA Biotechnology, Inc.). First filing Jun 2, 2026, latest Jun 2, 2026.
Sergei Gryaznov files SEC Form 4 as officer at MAIA (MAIA Biotechnology, Inc.). Since Jun 2, 2026, Sergei Gryaznov has reported 1 open-market buy worth $2,690 and 0 open-market sells worth $0, the latest filed on Jun 2, 2026.
A track record needs three past buys with six months of prices behind them; Sergei Gryaznov has 0, so none is measured yet.
The newest scored trade: bought $2,690 of MAIA on Jun 1, 2026, filed Jun 2, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $2,690 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MAIA: MAIA Biotechnology, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | MAIA Biotechnology, Inc. | $2,690 2,000 shares | +4% | +49% from low-56% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MAIA MAIA Biotechnology, Inc. | POpen-market purchase Common Stock | +2,000 | $1.35 | $2,690 | 46,511 | Jun 2, 2026 |
| May 29, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +400,000 | $0.00 | $0 | 400,000 | Jun 1, 2026 |
| Apr 10, 2026 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +400,000 | $0.00 | $0 | 400,000 | Apr 14, 2026 |
| May 14, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +200,000 | $0.00 | $0 | 200,000 | May 16, 2025 |
| Feb 10, 2025 | MAIA MAIA Biotechnology, Inc. | AGrant or award Stock Optionsderivative | +200,000 | $0.00 | $0 | 200,000 | Feb 12, 2025 |
Questions about Sergei Gryaznov
Answered from the filings on this page, as of the latest one.
Is Sergei Gryaznov buying or selling?
In the last 12 months Sergei Gryaznov reported 1 open-market buy worth $2,690 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $2,690 of MAIA on Jun 1, 2026. Grants, option exercises and tax withholding are not counted.
How did Sergei Gryaznov's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sergei Gryaznov has 0.
Where does Sergei Gryaznov file Form 4?
Sergei Gryaznov has filed Form 4 at MAIA (MAIA Biotechnology, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.